One class of drug used to treat type 2 diabetes may not reduce the risk of death when compared with placebo, suggests new findings. But two other commonly prescribed drugs do significantly reduce mortality and could perhaps be better options. The research, led by scientists from Imperial College London and published in the Journal of […]
Read More… from Popular diabetes drug may not reduce risk of death